A detailed history of Gabelli Funds LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Gabelli Funds LLC holds 38,000 shares of STIM stock, worth $30,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,000
Previous 48,000 20.83%
Holding current value
$30,400
Previous $86,000 67.44%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.73 - $2.0 $7,300 - $20,000
-10,000 Reduced 20.83%
38,000 $28,000
Q2 2024

Aug 13, 2024

BUY
$1.73 - $4.81 $38,925 - $108,224
22,500 Added 88.24%
48,000 $86,000
Q4 2023

Feb 13, 2024

SELL
$1.05 - $2.9 $45,962 - $126,944
-43,774 Reduced 63.19%
25,500 $73,000
Q3 2023

Nov 08, 2023

SELL
$1.29 - $2.22 $173,121 - $297,930
-134,203 Reduced 65.95%
69,274 $93,000
Q2 2023

Aug 10, 2023

SELL
$2.07 - $2.92 $14,489 - $20,440
-7,000 Reduced 3.33%
203,477 $437,000
Q1 2023

May 12, 2023

SELL
$2.81 - $6.71 $8,430 - $20,130
-3,000 Reduced 1.41%
210,477 $612,000
Q4 2022

Feb 13, 2023

SELL
$2.74 - $6.87 $80,556 - $201,978
-29,400 Reduced 12.1%
213,477 $1.47 Million
Q3 2022

Nov 10, 2022

SELL
$2.35 - $4.66 $55,225 - $109,510
-23,500 Reduced 8.82%
242,877 $772,000
Q2 2022

Aug 12, 2022

BUY
$2.09 - $3.71 $25,707 - $45,633
12,300 Added 4.84%
266,377 $855,000
Q1 2022

May 13, 2022

BUY
$2.84 - $4.52 $23,288 - $37,064
8,200 Added 3.34%
254,077 $770,000
Q4 2021

Feb 11, 2022

BUY
$3.87 - $6.59 $114,497 - $194,971
29,586 Added 13.68%
245,877 $1.1 Million
Q3 2021

Nov 12, 2021

BUY
$6.22 - $15.54 $447,516 - $1.12 Million
71,948 Added 49.85%
216,291 $1.42 Million
Q2 2021

Aug 13, 2021

BUY
$10.15 - $17.25 $60,889 - $103,482
5,999 Added 4.34%
144,343 $2.31 Million
Q1 2021

May 14, 2021

BUY
$10.6 - $21.27 $808,769 - $1.62 Million
76,299 Added 122.97%
138,344 $1.71 Million
Q3 2020

Nov 06, 2020

BUY
$1.82 - $5.87 $77,431 - $249,739
42,545 Added 218.18%
62,045 $302,000
Q4 2019

Feb 14, 2020

BUY
$4.03 - $9.22 $78,585 - $179,790
19,500 New
19,500 $88,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $21.6M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.